Study to evaluate the effectiveness of adalimumab in clinical practice on bone density and metabolism in patients with psoriatic arthritis.
Phase of Trial: Phase IV
Latest Information Update: 29 Jul 2015
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 29 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.